ANDOVER, Mass., Nov. 12, 2010 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced that Dr. Hung Wen Lin, Ph.D., research fellow at the Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami, Miller School of Medicine, has been selected as the recipient of the fourth annual American Heart Association-Philips Resuscitation Fellowship Award.
The $100,000 grant, which is funded over a two-year period by Philips, is intended to encourage young investigators in the early stages of their careers to pursue basic and clinical research related to resuscitation. The American Heart Association-Philips Resuscitation Fellowship Award will enable Dr. Lin to continue his research on the effects of cardiac arrest on brain circulation. It's anticipated that Dr. Lin's research will contribute to identifying a standard therapy to preserve brain function following cardiac arrest.
"With advanced technology and a resolve to support the resuscitation and emergency care community in saving lives, Philips has long been a champion for the advancement of research," said Derek Smith, senior vice president and general manager, Therapeutic Care, Philips Healthcare. "In that spirit, we are honored to support the AHA and its international community of thought leaders with funding in pursuit of innovation."
Dr. Lin will be presented with the Fellowship Award on November 13, 2010, at the Resuscitation Science Symposium (ReSS) meeting, which is held each year in conjunction with the AHA's Scientific Sessions. This year's meeting will take place in Chicago, Illinois, at the McCormick Place Convention Center.
Philips is a world class leader in emergency care and resuscitation solutions. The Philips family of resuscitation products reflects the principles and intent of the newly unveiled American Heart Association (AHA) Guidelines 2010 for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiac Care, as well as the new European Resuscitation Council (ERC) Guidelines for Resuscitation 2010.
Philips HeartStart defibrillators are tailored to support the needs of all types of responders, from lay people to professional healthcare providers. Philips defibrillators combine ease-of-use benefits, such as voice instructions and compact design, with clinically proven features for heart rhythm assessment and defibrillation as well as CPR coaching and data management.
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide. With sales of $32.3 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
|SOURCE Royal Philips Electronics|
Copyright©2010 PR Newswire.
All rights reserved